Acute myeloid leukemia with IDH1 and IDH2 mutations: 2021 treatment algorithm

por Issa, Ghayas C., DiNardo, Courtney D.
Publicado no Blood Cancer J (2021)

Novel agents in Waldenström macroglobulinemia

por Issa, Ghayas C, Ghobrial, Irene M, Roccaro, Aldo M
Publicado em 2011

Nucleophosmin 1 Mutations in Acute Myeloid Leukemia

por Zarka, Jabra, Short, Nicholas J., Kanagal-Shamanna, Rashmi, Issa, Ghayas C.
Publicado no Genes (Basel) (2020)

Epigenetic modifications as key regulators of Waldenstrom's Macroglobulinemia biology

por Sacco, Antonio, Issa, Ghayas C, Zhang, Yong, Liu, Yang, Maiso, Patricia, Ghobrial, Irene M, Roccaro, Aldo M
Publicado em 2010

Impact of complete molecular response on survival in patients with Philadelphia chromosome–positive acute lymphoblastic leukemia

por Short, Nicholas J., Jabbour, Elias, Sasaki, Koji, Patel, Keyur, O’Brien, Susan M., Cortes, Jorge E., Garris, Rebecca, Issa, Ghayas C., Garcia-Manero, Guillermo, Luthra, Rajyalakshmi, Thomas, Deborah, Kantarjian, Hagop, Ravandi, Farhad
Publicado no Blood (2016)

NPM1 mutant variant allele frequency correlates with leukemia burden but does not provide prognostic information in NPM1-mutated AML

por Abbas, Hussein A., Ravandi, Farhad, Loghavi, Sanam, Patel, Keyur P., Borthakur, Gautam, Kadia, Tapan M., Jabbour, Elias, Takahashi, Koichi, Cortes, Jorge, Issa, Ghayas C., Konopleva, Marina, Kantarjian, Hagop M., Short, Nicholas J.
Publicado no Am J Hematol (2019)

Emergence of BCR–ABL1 Fusion in AML Post–FLT3 Inhibitor-Based Therapy: A Potentially Targetable Mechanism of Resistance – A Case Series

por Alotaibi, Ahmad S., Yilmaz, Musa, Loghavi, Sanam, DiNardo, Courtney, Borthakur, Gautam, Kadia, Tapan M., Thakral, Beenu, Pemmaraju, Naveen, Issa, Ghayas C., Konopleva, Marina, Short, Nicholas J., Patel, Keyur, Tang, Guilin, Ravandi, Farhad, Daver, Naval
Publicado no Front Oncol (2020)

Hyper-CVAD + ponatinib vs. hyper-CVAD + dasatinib as frontline therapy for Ph-positive ALL: a propensity score analysis

por Sasaki, Koji, Jabbour, Elias, Ravandi, Farhad, Short, Nicholas J., Thomas, Deborah, Garcia-Manero, Guillermo, Daver, Naval, Kadia, Tapan, Konopleva, Marina, Jain, Nitin, Issa, Ghayas C., Jeanis, Vicki, Moore, Gal, Garris, Rebecca, Pemmaraju, Naveen, Cortes, Jorge E., O'Brien, Susan, Kantarjian, Hagop
Publicado no Cancer (2016)

Tyrosine kinase inhibitor discontinuation in patients with chronic myeloid leukemia: a single-institution experience

por Chamoun, Kamal, Kantarjian, Hagop, Atallah, Rami, Gonzalez, Graciela Nogueras, Issa, Ghayas C., Rios, Mary Beth, Garcia-Manero, Guillermo, Borthakur, Gautam, Ravandi, Farhad, Jain, Nitin, Daver, Naval, Konopleva, Marina, DiNardo, Courtney D., Kadia, Tapan, Pemmaraju, Naveen, Jabbour, Elias, Cortes, Jorge
Publicado no J Hematol Oncol (2019)

Impact of numerical variation, allele burden, mutation length and co-occurring mutations on the efficacy of tyrosine kinase inhibitors in newly diagnosed FLT3- mutant acute myeloid...

por Abou Dalle, Iman, Ghorab, Ahmad, Patel, Keyur, Wang, Xuemei, Hwang, Hyunsoo, Cortes, Jorge, Issa, Ghayas C., Yalniz, Fevzi, Sasaki, Koji, Chihara, Dai, Price, Allyson, Kadia, Tapan, Pemmaraju, Naveen, Daver, Naval, DiNardo, Courtney, Ravandi, Farhad, Kantarjian, Hagop M., Borthakur, Gautam
Publicado no Blood Cancer J (2020)

Clonal chromosomal abnormalities appearing in Philadelphia chromosome–negative metaphases during CML treatment

por Issa, Ghayas C., Kantarjian, Hagop M., Gonzalez, Graciela Nogueras, Borthakur, Gautam, Tang, Guilin, Wierda, William, Sasaki, Koji, Short, Nicholas J., Ravandi, Farhad, Kadia, Tapan, Patel, Keyur, Luthra, Raja, Ferrajoli, Alessandra, Garcia-Manero, Guillermo, Rios, Mary Beth, Dellasala, Sara, Jabbour, Elias, Cortes, Jorge E.
Publicado no Blood (2017)

Inotuzumab Ozogamicin in Combination with Low-Intensity Chemotherapy (mini-hyper-CVD) with or without Blinatumomab vs. Standard Intensive Chemotherapy (hyper-CVAD) as Frontline The...

por Jabbour, Elias, Sasaki, Koji, Ravandi, Farhad, Short, Nicholas J., Garcia-Manero, Guillermo, Daver, Naval, Kadia, Tapan, Konopleva, Marina, Jain, Nitin, Cortes, Jorge, Issa, Ghayas C., Jacob, Jovitta, Kwari, Monica, Thompson, Philip, Garris, Rebecca, Pemmaraju, Naveen, Yilmaz, Musa, O’Brien, Susan, Kantarjian, Hagop
Publicado no Cancer (2019)

Characteristics and outcomes of patients with therapy-related acute myeloid leukemia with normal karyotype

por Samra, Bachar, Richard-Carpentier, Guillaume, Kadia, Tapan M., Ravandi, Farhad, Daver, Naval, DiNardo, Courtney D., Issa, Ghayas C., Bose, Prithviraj, Konopleva, Marina Y., Yilmaz, Musa, Ohanian, Maro, Borthakur, Gautam, Garcia-Manero, Guillermo, Pierce, Sherry, Cortes, Jorge E., Kantarjian, Hagop, Short, Nicholas J.
Publicado no Blood Cancer J (2020)

Prognostic impact of complete remission with MRD negativity in patients with relapsed or refractory AML

por Short, Nicholas J., Rafei, Hind, Daver, Naval, Hwang, Hyunsoo, Ning, Jing, Jorgensen, Jeffrey L., Kadia, Tapan M., DiNardo, Courtney D., Wang, Sa A., Jabbour, Elias, Popat, Uday, Oran, Betul, Cortes, Jorge, Konopleva, Marina, Yilmaz, Musa, Issa, Ghayas C., Kantarjian, Hagop, Ravandi, Farhad
Publicado no Blood Adv (2020)

Prognostic and therapeutic impacts of mutant TP53 variant allelic frequency in newly diagnosed acute myeloid leukemia

por Short, Nicholas J., Montalban-Bravo, Guillermo, Hwang, Hyunsoo, Ning, Jing, Franquiz, Miguel J., Kanagal-Shamanna, Rashmi, Patel, Keyur P., DiNardo, Courtney D., Ravandi, Farhad, Garcia-Manero, Guillermo, Takahashi, Koichi, Konopleva, Marina, Daver, Naval, Issa, Ghayas C., Andreeff, Michael, Kantarjian, Hagop, Kadia, Tapan M.
Publicado no Blood Adv (2020)

Prognostic significance of day 14 bone marrow evaluation in adults with Philadelphia chromosome-negative ALL

por Short, Nicholas J., Kantarjian, Hagop, Sasaki, Koji, Cortes, Jorge E., Ravandi, Farhad, Thomas, Deborah, Garcia-Manero, Guillermo, Khouri, Issa, Kebriaei, Partow, Champlin, Richard E., Pierce, Sherry, Issa, Ghayas C., Konopleva, Marina, Kadia, Tapan M., Bueso-Ramos, Carlos, Khoury, Joseph D., Jain, Nitin, O’Brien, Susan M., Jabbour, Elias
Publicado no Cancer (2016)

Targeted next-generation sequencing of circulating cell-free DNA vs bone marrow in patients with acute myeloid leukemia

por Short, Nicholas J., Patel, Keyur P., Albitar, Maher, Franquiz, Miguel, Luthra, Rajyalakshmi, Kanagal-Shamanna, Rashmi, Wang, Feng, Assi, Rita, Montalban-Bravo, Guillermo, Matthews, Jairo, Ma, Wanlong, Loghavi, Sanam, Takahashi, Koichi, Issa, Ghayas C., Kornblau, Steven M., Jabbour, Elias, Garcia-Manero, Guillermo, Kantarjian, Hagop M., Estrov, Zeev, Ravandi, Farhad
Publicado no Blood Adv (2020)

Ultra-accurate Duplex Sequencing for the assessment of pretreatment ABL1 kinase domain mutations in Ph+ ALL

por Short, Nicholas J., Kantarjian, Hagop, Kanagal-Shamanna, Rashmi, Sasaki, Koji, Ravandi, Farhad, Cortes, Jorge, Konopleva, Marina, Issa, Ghayas C., Kornblau, Steven M., Garcia-Manero, Guillermo, Garris, Rebecca, Higgins, Jake, Pratt, Gabriel, Williams, Lindsey N., Valentine, Charles C., Rivera, Victor M., Pritchard, Justin, Salk, Jesse J., Radich, Jerald, Jabbour, Elias
Publicado no Blood Cancer J (2020)

Prognostic impact of pretreatment cytogenetics in adult Philadelphia chromosome-negative ALL in the era of MRD

por Issa, Ghayas C., Kantarjian, Hagop, Yin, C. Cameron, Qiao, Wei, Ravandi, Farhad, Thomas, Deborah, Short, Nicholas J., Sasaki, Koji, Garcia-Manero, Guillermo, Kadia, Tapan M., Cortes, Jorge E., Daver, Naval, Borthakur, Gautam, Jain, Nitin, Konopleva, Marina, Khouri, Issa, Kebriaei, Partow, Champlin, Richard E., Pierce, Sherry, O'Brien, Susan M., Jabbour, Elias
Publicado no Cancer (2016)

Poor outcomes associated with +der(22)t(9;22) and -9/9p in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia receiving chemotherapy plus a tyrosine kinase...

por Short, Nicholas J., Kantarjian, Hagop M., Sasaki, Koji, Ravandi, Farhad, Ko, Heidi, Yin, C. Cameron, Garcia-Manero, Guillermo, Cortes, Jorge E., Garris, Rebecca, O'Brien, Susan M., Patel, Keyur, Khouri, Maria, Thomas, Deborah, Jain, Nitin, Kadia, Tapan M., Daver, Naval, Benton, Christopher B., Issa, Ghayas C., Konopleva, Marina, Jabbour, Elias
Publicado no Am J Hematol (2017)